Valsartan scandal draws in a further two companies
The global investigation into the valsartan scandal continues to broaden, as two additional companies are drawn under the lens of the FDA and EMA.
Archives for August 21, 2018
With $3m in funding, tech firm looks to drive drug development using EHR data
RDMD has secured $3m in seed funding to further develop its technology platform, which bridges the gap between patients and pharma, says CEO.
Elligo targets gender equality in trials: ‘There is still a long way to go’
Elligo Health Research has partnered with Women’s Health USA to help improve female patient numbers in clinical trials.
Clinical trial boom boosts Cryoport revenues 59% in Q2 2018
Cryoport is supporting a record number of clinical trials driven by rapid growth in regenerative medicine – a space that will continue to grow and outpace the pharmaceutical industry, says CCO.
Novo Nordisk looks to ‘eliminate hypoglycaemia’ with $800m insulin deal
Novo Nordisk has acquired Ziylo to gain access to a glucose responsive insulin platform it says could help eliminate hypoglycaemic episodes.
BWXT completes acquisition of Sotera Health’s medical isotope unit
BWXT has officially completed its acquisition of Nordion Inc., inheriting a portfolio of radioisotope products.